Absence of DNA human papillomavirus type 16 in Mexican women with normal pap smear

International Journal of Virology

Volumn 2, Issue 1, 2006, Pages 59-62

  González Losa, Maria del Refugio ^a   Hidalgo Martínez, Ana C ^a   Manzano Cabrera, Luis ^a   Estrada Saldivar, Aremi ^b   Puerto Solís, Marylin ^a  

^a UNIVERSIDAD AUTÓNOMA DE YUCATÁN   (Mexico)

^b Hospital General del Instituto de Seguridad al Servicio de los Trabajadores del Estado (ISSSTE)   (Mexico)

Author keywords

Human papillomavirus; Mexican women; Pap smear

Indexed keywords

BETA GLOBIN; VIRUS DNA; WART VIRUS VACCINE;

ADULT; ARTICLE; CONDYLOMA; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MEXICO; PAPANICOLAOU TEST; POLYMERASE CHAIN REACTION; PREVALENCE; QUESTIONNAIRE; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS DIAGNOSIS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33748149489     PISSN: 18164900     EISSN: None     Source Type: Journal    
DOI: 10.3923/ijv.2006.59.62     Document Type: Article

References (14)

1. Bosch, F.X., 2003. Cervical cancer. Advances in prevention and knowledge of its etiology. Salud Publica de Mexico, pp: S297-298.
2. Calleja-Macias, I.E., L.L. Villa, J.C. Prado, M. Kalantari, B. Allan and A.L. Williamson et al., 2005. Worldwide genomic diversity of the high-risk human papillomavirus types 31, 35, 52 and 58, four close relatives of human papillomavirus type 16. J. Virol., 79:13630-13640.
3. Clifford, G.M., J.S. Smith, M. Plumier, N. Muñoz and S. Franceschi, 2003. Human papillomavirus type in invasive cervical cancer worldwide: A meta-analysis. Br. J. Cancer, 88: S63-73.
4. Flores, Y., E. Lazcano, K. Shah, A. Lorincs, M. Hernández and J. Salmerón, 2003. Improving cervical cancer screening in Mexico: Results from the Morelos HPV Study. Salud Publica Mex., 45: S388-397.
5. García-Carranca, A., 2003. Vaccines against human papillomavirus and perspectives for the prevention and control of cervical cancer. Salud Pub Mex., 45: S437-447.
6. Giuliano, A.R., M. Papenfuss, M. Abrahamsen and P. Inserra, 2002. Differences in Factors Associated with Oncogenic and Nononcogenic Human Papillomavirus Infection at the United States-Mexico Border. Cancer Epidemiol. Biomark. Prevent., 11: 930-934.
7. González-Losa, M.R., I. Rosado-Lopez, N. Valdez-González and M. Puerto-Solís, 2004. High prevalence of human papillomavirus type 58 in Mexican colposcopy patients. J. Clin. Virol., 29: 202-205.
8. Hernandez-Avila, M., C.E. Lazcano-Ponce, J. Berumen-Campos, A. Cruz-Valdez, P. Alonso-de Ruiz and G. González-Lira, 1997. Human papillomaviurs 16/18 infection and cervical cancer in Mexico: A case-control study. Arch. Med. Res., 28: 265-271.
9. Lazcano-Ponce, E., R. Herrero, N. Muñoz, A. Cruz, K. V. Shah and P. Alonso, 2001. Epidemiology of HPV infection among Mexican women with normal cervical cytology. Intl. J. Cancer, 91: 412-420.
10. Mandic, A. and T. Vujkov, 2004. Human papillomavirus vaccine as a new way of preventing cervical cancer: A dream or the future? Ann. Oncol., 15: 197-200.
11. Rodriguez-Reyes, E.R., R.M. Cerda-Flores, N.P. Solis-Rios, J.M. Quiñones-perez and E.I. Cortés-Gutiérrez, 2003. Identification and typification of human papilloa virus in women using the Timely Detection of Cancer, rogram in Duragan, Mexico. Ginecol. Obstet. Mex., 71: 471-475.
12. Torroela-Kouri, M., S. Mosberger, A. Carrillo, A. Mohar, A. Meneses and M. Ibarra et al., 1998. HPV prevalence among Mexican women with neoplastoic and oral cervixes. Gynecol. Oncol., 70: 115-120.
13. Walboomers, J.M.M., M.V. Jacobs, M.M. Manos, F.X. Bosch, J.A. Kummer and K.V. Shah et al., 1999. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol., 189: 12-19.
14. Wheeler, C.M., T. Yamada, A. Hildesheim and S. Janison, 1997. Human papillomavirus type 16 sequence variants: Identification by E6 and L1 lineage-specific hybridization. J. Microbiol., 35: 11-19.